Riskpilot← Back to searchSign inGet full accessRÅHOLT ØRE NESE HALS AS
ASActiveOrg 926031376Gladbakkvegen 2A, 2070 RåholtMedical specialists activities · NACE 8622Est. 20206 employees
Revenue 2024
NOK 7,5M
+7% vs 2023
EBITDA margin
11.4%
+378% vs 2023
Equity ratio
51.5%
Financial strength
Net profit 2024
NOK 671K
+1106% vs 2023
| Revenue | NOK 7,5M | +7% |
| EBITDA | NOK 863K | +378% |
| Net profit | NOK 671K | +1106% |
| Total assets | NOK 1,5M | +50% |
| Equity | NOK 798K | +532% |
| Employees | 6 | — |
Legal name
RÅHOLT ØRE NESE HALS AS
Org number
926031376
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
25. november 2020
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legesenter innen spesialiteten øre, nese, hals, og virksomhet som står i forbindelse med dette.
Address
Gladbakkvegen 2A, 2070 Råholt
Phone
+4763979330
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 833 | 4 357 | 5 337 | 7 041 | 7 543 |
| Staff expenses | −510 | −3 631 | −3 550 | −4 762 | −4 258 |
| EBITDA | 73 | −1 013 | −227 | 181 | 863 |
| Depreciation & amort. | −29 | −183 | −211 | −124 | −191 |
| EBIT | 44 | −1 196 | −439 | 56 | 672 |
| Net financials | 0 | 0 | −1 | −0 | −0 |
| Profit before tax | 44 | −1 196 | −440 | 56 | 671 |
| Tax | 9 | −9 | −0 | −0 | −0 |
| Net profit | 36 | −1 187 | −440 | 56 | 671 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 417 | 1 380 | 1 356 | 1 032 | 1 547 |
| Equity | 60 | −1 127 | 71 | 126 | 798 |
| Long-term debt | 9 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 348 | 2 508 | 1 285 | 905 | 750 |
| Total debt | 1 357 | 2 508 | 1 285 | 905 | 750 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20202024
Equity ratio
51.5%
This company
38.2%
Market median
+35% vs market
20202024
Return on equity
84.2%
This company
18.4%
Market median
+358% vs market
20202024
Net profit margin
8.9%
This company
8.1%
Market median
+10% vs market
20202024
Asset turnover
4.87×
This company
1.12×
Market median
+335% vs market
20202024
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-11-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NH Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2024 | |
| Company | 40% | 40% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Niazmed Holding As
RÅHOLT ØRE NESE HALS AS Board members of RÅHOLT ØRE NESE HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nazanin Hejaz Niaz | Chief Executive Officer | 0 companies |
| Olav Skatvedt | Chairman | 0 companies |
| Amer Mohammad Niaz | Chairman | 0 companies |